Regular Exercise Improved Fatigue and Musculoskeletal Pain in Young Adult Psoriatic Patients without Psoriatic Arthritis

Fatigue and musculoskeletal pain are also frequent in patients with psoriasis (PsO) without arthritis (PsA). The current study aimed to assess the impact of an intervention program based on aerobic training to reduce fatigue and musculoskeletal pain in patients with PsO without PsA. A total of 118 male patients with PsO volunteered in the current interventional study and were randomly allocated to the experimental (n = 59) or control group (n = 59). The intervention consisted of a 16-week aerobic training program on a treadmill, three sessions per week, consisting of a warm-up, 35–50 min treadmill exercise (increasing 5 min/4 weeks) at a work intensity of 50–65% of peak heart-rate (increasing 5%/4 weeks), and cooling-down. The functional assessment of chronic illness therapy fatigue scale (FACIT-Fatigue), health assessment questionnaire disability index (HAQ-DI), and visual analog scale (VAS) were compared pre and post intervention. Nutritional intake, maximal aerobic power, lipid profile, serum markers of muscle damage, and body composition were also assessed. When compared to baseline, FACIT-Fatigue, HAQ-DI, and VAS scores were significantly improved without increasing markers of muscle damage. Fat mass percentage, lipid profile, and maximal oxygen consumption were also improved. In conclusion, a 16-week aerobic training program at moderate intensity was safe, well tolerated, and effective in psoriatic patients without PsA. Long-term follow-up studies are required to examine whether these promising results may improve clinical outcomes.

[1]  J. Merola,et al.  Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database , 2023, Dermatology and Therapy.

[2]  B. Sitter,et al.  Changes of inflammation in patients with psoriatic arthritis after high intensity interval training assessed by ultrasound and MRI, a randomized controlled trial , 2023, BMC Musculoskeletal Disorders.

[3]  D. Van Assche,et al.  The effectiveness of exercise and physical activity programs on fatigue and sleep in people with arthritis - A systematic review with meta-analysis. , 2023, Sleep medicine reviews.

[4]  A. Bhalerao,et al.  More than skin-deep: visceral fat is strongly associated with disease activity, function and metabolic indices in psoriatic disease , 2023, Arthritis Research & Therapy.

[5]  K. Chin,et al.  Metabolic Syndrome Screening and Nutritional Status of Patients with Psoriasis: A Scoping Review , 2023, Nutrients.

[6]  Youming Guo,et al.  Crosstalk between cholesterol metabolism and psoriatic inflammation , 2023, Frontiers in Immunology.

[7]  A. Chabowski,et al.  Effects of Hypolipidemic Drugs on Psoriasis , 2023, Metabolites.

[8]  J. Kruk,et al.  The Impact of Diet and Physical Activity on Psoriasis: A Narrative Review of the Current Evidence , 2023, Nutrients.

[9]  V. Gianfredi,et al.  Epidemiology of psoriasis in Italy: burden, cost, comorbidities and patients’ satisfaction. A systematic review , 2022, Acta bio-medica : Atenei Parmensis.

[10]  L. Coates,et al.  Sex-Specific Differences in Patients With Psoriatic Arthritis: A Systematic Review , 2022, The Journal of Rheumatology.

[11]  M. Musumeci,et al.  The role of lifestyle and nutrition in psoriasis: Current status of knowledge and interventions , 2022, Dermatologic therapy.

[12]  Tengyu Ma,et al.  Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence , 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  T. Bathen,et al.  Evaluating the Impact of High Intensity Interval Training on Axial Psoriatic Arthritis Based on MR Images , 2022, Diagnostics.

[14]  F. Guillemin,et al.  2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases , 2022, Annals of the Rheumatic Diseases.

[15]  F. Guillemin,et al.  Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs , 2022, RMD Open.

[16]  P. Sfikakis,et al.  Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients' perception? , 2022, Clinical and experimental rheumatology.

[17]  M. Dougados,et al.  Evaluation of the prevalence of musculoskeletal conditions in consecutive patients with skin psoriasis: a descriptive cross-sectional study , 2022, Rheumatology International.

[18]  L. Gossec,et al.  Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis , 2021, Rheumatology.

[19]  L. Skov,et al.  Musculoskeletal pain in psoriasis - relation to inflammation and additional value of ultrasound in psoriatic arthritis classification. , 2021, Rheumatology.

[20]  D. Boda,et al.  Management of psoriasis in children (Review) , 2021, Experimental and therapeutic medicine.

[21]  L. Skov,et al.  Musculoskeletal Pain in Patients with Psoriasis and its Influence on Health-related Quality of Life: Results from a Danish Populationbased Survey , 2021, Acta dermato-venereologica.

[22]  J. Thyssen,et al.  Disease burden, symptoms and use of analgesics in patients with psoriasis with or without psoriatic arthritis: a cross-sectional study. , 2021, Journal of the American Academy of Dermatology.

[23]  C. Prati,et al.  Psoriatic arthritis and physical activity: a systematic review , 2021, Clinical Rheumatology.

[24]  A. Ogdie,et al.  The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population‐Based Study , 2021, Arthritis & rheumatology.

[25]  F. Perrotta,et al.  New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review , 2021, Rheumatology and Therapy.

[26]  N. Kanda Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated , 2021, International journal of molecular sciences.

[27]  C. Ballegaard,et al.  Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study. , 2020, Rheumatology.

[28]  L. León,et al.  Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project. , 2020, Reumatologia clinica.

[29]  F. Aubin,et al.  Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk. , 2020, Rheumatology.

[30]  R. Queiró Analysis of the HAQ-DI components in psoriatic arthritis patients with and without low disease impact. , 2020, Rheumatology.

[31]  V. Azevedo,et al.  The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis , 2020, Advances in Rheumatology.

[32]  P. Jarrett,et al.  What are the barriers to physical activity in patients with chronic plaque psoriasis? , 2020, The British journal of dermatology.

[33]  A. V. Van Voorhees,et al.  Physical activity engagement and responses to exercise in plaque psoriasis: a multifactorial investigation of influential factors , 2020, The Journal of dermatological treatment.

[34]  B. Eliasson,et al.  Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up , 2020, Arthritis Research & Therapy.

[35]  E. Kontopantelis,et al.  National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study , 2020, BMJ.

[36]  M. Dalamaga,et al.  Deciphering the Association Between Psoriasis and Obesity: Current Evidence and Treatment Considerations , 2020, Current Obesity Reports.

[37]  L. Coates,et al.  Treatment guidelines in psoriatic arthritis , 2020, Rheumatology.

[38]  L. Auker,et al.  What are the barriers to physical activity in patients with chronic plaque psoriasis?* , 2020, The British journal of dermatology.

[39]  G. Haugeberg,et al.  Adiposity and Physical Activity as Risk Factors for Developing Psoriatic Arthritis: Longitudinal Data From a Population‐Based Study in Norway , 2019, Arthritis care & research.

[40]  G. Haugeberg,et al.  Impact of High‐Intensity Interval Training on Disease Activity and Disease in Patients With Psoriatic Arthritis: A Randomized Controlled Trial , 2019, Arthritis care & research.

[41]  M. Ladouceur,et al.  The economic burden of psoriasis with high comorbidity among privately insured patients in the United States , 2019, Journal of medical economics.

[42]  Jasvinder A. Singh,et al.  2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis , 2018, Arthritis care & research.

[43]  G. Haugeberg,et al.  Effect of high-intensity interval training on cardiovascular disease risk factors and body composition in psoriatic arthritis: a randomised controlled trial , 2018, RMD Open.

[44]  A. Martorell,et al.  Moderate Psoriasis: A Proposed Definition. , 2017, Actas dermo-sifiliograficas.

[45]  B. Dofitas,et al.  Atorvastatin as adjunctive therapy for chronic plaque type psoriasis versus betamethasone valerate alone: A randomized, double-blind, placebo-controlled trial , 2017, Indian journal of dermatology, venereology and leprology.

[46]  R. Omdal,et al.  Fatigue in psoriasis: a controlled study , 2017, The British journal of dermatology.

[47]  D. Gladman,et al.  The Development of Psoriatic Arthritis in Patients With Psoriasis Is Preceded by a Period of Nonspecific Musculoskeletal Symptoms: A Prospective Cohort Study , 2016, Arthritis & rheumatology.

[48]  A. Bidari,et al.  The acute effect of maximal exercise on plasma beta-endorphin levels in fibromyalgia patients , 2016, The Korean journal of pain.

[49]  B. Shea,et al.  International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials , 2016, Annals of the rheumatic diseases.

[50]  M. D. de Wit,et al.  Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries. , 2016, Joint, bone, spine : revue du rhumatisme.

[51]  H. Tariq,et al.  Etanercept-induced myositis: do we have to stop it? A surprising outcome , 2016, BMJ Case Reports.

[52]  L. Serra-Majem,et al.  The ANIBES Study on Energy Balance in Spain: Design, Protocol and Methodology , 2015, Nutrients.

[53]  T. Torres,et al.  Levels of Physical Activity in Patients with Severe Psoriasis: A Cross-Sectional Questionnaire Study , 2014, American Journal of Clinical Dermatology.

[54]  A. Qureshi,et al.  The association between physical activity and the risk of incident psoriasis. , 2012, Archives of dermatology.

[55]  F. Sampogna,et al.  Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. , 2012, Acta dermato-venereologica.

[56]  D. Gladman,et al.  Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritis , 2007, Annals of the rheumatic diseases.

[57]  Shumei S. Sun,et al.  Development of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveys. , 2003, The American journal of clinical nutrition.

[58]  Y. Epstein,et al.  Are psoriatic patients at risk of heat intolerance? , 1991, The British journal of dermatology.

[59]  B. Kumar,et al.  Palmoplantar lesions in psoriasis: a study of 3065 patients. , 2002, Acta dermato-venereologica.